Security Snapshot

Connect Biopharma Holdings Ltd - Ordinary Shares (CNTB) Institutional Ownership

CUSIP: G23549101

13F Institutional Holders and Ownership History from Q3 2025 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

55

Shares (Excl. Options)

13,874,380

Price

$2.38

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+1,125,656
Value change
+$2,553,909
Number of holders
55
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
62,075,472
SEC-reported price per share
$2.26
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares is tracked under CUSIP G23549101.
  • 55 institutions reported positions in Q2 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 40 to 55 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $32,367,682 to $33,020,003.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 55 institutions filings for Q2 2026.

Open SEC evidence

Security key

G23549101

Latest holder period

Q2 2026

13F holders

55

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
CNTB
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Panacea Innovation Ltd 21% -1.4% $36,848,000 +$3,248,000 13,160,000 +9.7% Panacea Innovation Limited 31 Mar 2026

As of 30 Jun 2026, 55 institutional investors reported holding 13,874,380 shares of Connect Biopharma Holdings Ltd - Ordinary Shares (CNTB). This represents 22% of the company’s total 62,075,472 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
22%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Ikarian Capital, LLC 7.3% 4,538,534 -16% 1.8% $10,801,710
683 Capital Management, LLC 2.1% 1,285,000 +43% 0.28% $3,058,300
BOOTHBAY FUND MANAGEMENT, LLC 1.6% 973,732 -21% 0.04% $2,317,482
BlackRock, Inc. 1.4% 871,653 0% $2,074,534
PERCEPTIVE ADVISORS LLC 1.3% 792,696 0% 0.03% $1,886,616
ADAR1 Capital Management, LLC 1.1% 700,000 -5.7% 0.08% $1,666,000
BML Capital Management, LLC 0.92% 573,287 +40% 0.78% $1,364,423
SILVERARC CAPITAL MANAGEMENT, LLC 0.88% 545,000 0.14% $1,297,100
Richmond Brothers, Inc. 0.86% 535,612 +12% 0.66% $1,274,755
Knott David M Jr 0.72% 444,862 +15% 0.57% $1,058,772
Stonepine Capital Management, LLC 0.59% 364,254 +18% 0.66% $866,925
MARSHALL WACE, LLP 0.54% 335,642 +408% 0% $798,830
GEODE CAPITAL MANAGEMENT, LLC 0.41% 257,454 +701% 0% $612,740
TWO SIGMA INVESTMENTS, LP 0.32% 199,381 +320% 0% $474,527
DIADEMA PARTNERS LP 0.32% 196,985 -1.8% 0.18% $468,824
Burkehill Global Management, LP 0.24% 150,000 0% 0.01% $357,000
VANGUARD PORTFOLIO MANAGEMENT LLC 0.17% 102,755 0% $244,557
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.16% 102,148 -63% 0% $243,112
RENAISSANCE TECHNOLOGIES LLC 0.14% 87,300 -28% 0% $207,774
NORTHERN TRUST CORP 0.13% 82,862 0% $197,212
SIMPLEX TRADING, LLC 0.13% 81,948 0.01% $195,036
STATE STREET CORP 0.11% 66,700 0% $158,746
UBS Group AG 0.11% 66,451 +201267% 0% $158,153
Persistent Asset Partners Ltd 0.08% 49,873 -1.7% 0.04% $118,698
Koa Wealth Management, LLC 0.08% 49,600 0% 0.08% $118,048

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
4
Latest
Q2 2026
Rows shown
1-4 of 4
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 13,874,380 $33,020,003 +$2,553,909 $2.38 55
2026 Q1 12,746,434 $32,367,682 +$11,059,918 $2.62 40
2025 Q4 8,464,921 $23,870,814 +$21,721,782 $2.82 28
2025 Q3 1,621,133 $2,443,403 +$2,443,403 $1.48 15
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .